Anuh Pharma Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1983, the company has established itself as a leader in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) and formulations. With a focus on therapeutic areas such as oncology, cardiology, and anti-infectives, Anuh Pharma is renowned for its commitment to innovation and quality. The company’s unique approach to product development and stringent quality control measures have earned it a strong market position and recognition for excellence. Over the years, Anuh Pharma has achieved significant milestones, including regulatory approvals from major global health authorities, further solidifying its reputation in the competitive pharmaceutical landscape.
How does Anuh Pharma Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Anuh Pharma Limited's score of 16 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Anuh Pharma Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions figures or reduction initiatives available, it is unclear how Anuh Pharma Limited is addressing climate change within its operations. The absence of data may reflect a broader industry context where companies are increasingly expected to disclose their environmental impact and set ambitious targets for emissions reduction. Given the current lack of information, stakeholders may look for future updates from Anuh Pharma Limited regarding their climate commitments and any potential initiatives aimed at reducing their carbon footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Anuh Pharma Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
